FDA Opioid Action Plan Means More Advisory Committees And A New Look At REMS, PMRs

FDA announced February 4 that it is undergoing a “far-reaching action plan” to assess its approach to opioid medications in a bid to resolve one of the final obstacles blocking confirmation of Robert Califf as FDA Commissioner.